Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article April 25 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Research Article April 25 2025
The oral CDK9 inhibitor voruciclib combined with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Research Article April 25 2025
Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4+ T cells in MDS.
Research Article April 25 2025
Activity of STAMP inhibitors in ABL2 rearranged Acute Lymphoblastic Leukemia is dependent on the Abl2 SH3 domain
Research Article April 16 2025
Olfactory Receptors as Tumor Suppressors in Cutaneous T-Cell Lymphoma via p38γ Pathway Modulation
Research Article April 16 2025
Outcomes of Myeloablative Allogeneic Hematopoietic Cell Transplantation with Omidubicel vs Haploidentical and Unrelated Donor Sources
Research Article April 16 2025
Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma
Research Article April 16 2025
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: a Real-World Experience
Brief Report April 15 2025
Magnetic resonance spectroscopy-based detection of response to therapy targeting glutaminolysis in lymphoma
Research Article April 4 2025
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myeloma
Research Article April 3 2025
Quality of life, fatigue, depression, attention deficits and pain after childhood Langerhans cell histiocytosis
Research Article April 3 2025
Ambroxol induces myeloma cell death by inhibiting autophagy
Brief Report April 3 2025
Risk Factors and Clinical Impact of Cytomegalovirus DNAemia in patients with Multiple Myeloma Treated with Teclistamab
Brief Report April 3 2025
Reduced CD20 Expression yields Inferior Survival in Patients with B Cell Lymphoma Treated with CD20xCD3 Antibodies
Research Article March 21 2025
Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling
Research Article March 11 2025
Discovery of a novel class NSD2 inhibitor for t(4;14)-positive multiple myeloma
Research Article March 10 2025
Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant
Review Article March 10 2025
Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation
Brief Report March 10 2025
Genomic Landscape and Clonal Architecture in Pediatric Myeloid Neoplasms with Chromosome 7 Deletions
Brief Report March 6 2025
Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms
Research Article March 3 2025
Phase 1 Trial of Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone for AML and High-Grade Myeloid Neoplasm
Research Article March 3 2025
Phase 2 trial of daratumumab, cyclophosphamide, thalidomide and dexamethasone in newly diagnosed multiple myeloma
Research Article March 3 2025
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms
Research Article January 16 2025
Clarithromycin, Ixazomib, Pomalidomide, Dexamethasone for Relapsed/Refractory Myeloma: Survival and Correlative Analysis
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals